Bedside-to-bench, not bench-to-bedside, is the best approach so far in neuropathic pain research

The traditional bench-to-bedside approach of translational research has yielded only one approved therapy for neuropathic pain, so far. However, multimodal approaches offer hope for the future, explained Professor Nadine Attal during her plenary lecture at NeuPSIG 2019.